Medicine supervisor bans turnover of some Indian preparations
The State Service of Ukraine for Medicines and Drugs Control has temporarily banned the sale and application of several preparations made by Genom Biotech Pvt. Ltd. (India).
The authority posted its resolution dated November 28 on its official website.
According to the resolution, the authority temporarily bans turnover of six Indian preparations LANZA, COFEX, SIGAN, ENZYMTAL, COLDFLU and TILDA.
In addition, the authority banned Espumisan preparation manufactured by Berlin-Chemie (Menarini Group, Germany) and Ringer's solution.
Advertising
Advertising
MORE ABOUT
Customs Service: Explosion takes place at Ukrposhta customs post at Kyiv customs office, shipment intended for export from Ukraine
20:16, 30.10.2025
Ukrainian Red Cross and Ukraine's State Archival Service sign cooperation memo
10:34, 24.09.2025
Ukrainian Red Cross and National Agency for Civil Service sign cooperation memo
09:09, 19.09.2025
Ukraine to restrict imports of Indian fuel from Oct 1
17:57, 15.09.2025
Patient organizations ask to unblock resources for purchasing innovative drugs for patients with orphan diseases
17:54, 05.09.2025
LATEST
Ukraine's State Agency revises claims about UAH 6.6 bln road through Bukovel
20:30, 05.12.2025
G7, EU countries considering complete ban on oil transportation from Russia instead of price cap – media
20:29, 05.12.2025
Intl support for humanitarian demining since 2022 reaches nearly $1.5 bln – Economy Minister
19:42, 05.12.2025
Eighty-three candidates apply for four Energoatom Supervisory Board seats
14:02, 05.12.2025
Vodafone Ukraine announces another buy-out of eurobonds for $1.16 mln